Investor Overview Press Releases November 18, 2024 Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline November 18, 2024 Aclaris Therapeutics Announces $80 Million Private Placement November 6, 2024 Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update View all » Events Nov 18, 20248:30 AM EST Aclaris Corporate Update Sep 17, 20248:00 AM EDT 2024 Cantor Global Healthcare Conference Jun 11, 202411:20 AM EDT Goldman Sachs Global Healthcare Conference View all » Feature Presentation ITK Portfolio
November 18, 2024 Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
November 6, 2024 Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
